Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03310905 · ClinicalTrials.gov registry record · NA
Abdominal Wall Transplant
A NA study of Transplant;Failure,Kidney and Transplant; Failure, Liver, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT03310905 is a NA study of Transplant;Failure,Kidney and Transplant; Failure, Liver that is actively recruiting participants, run by Duke University. The registered enrollment target is 5 participants, below the 90-participant average among 5 other Transplant;Failure,Kidney trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03310905, a NA study of Transplant;Failure,Kidney and Transplant; Failure, Liver, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to determine the safety and efficacy of abdominal wall transplantation as a treatment for the reconstruction of abdominal wall defects. Abdominal wall transplantation may be performed alone or in combination with another transplant.
Conditions Studied
Interventions
- PROCEDURE Abdominal Wall Transplant with another solid organ transplant
- PROCEDURE Abdominal Wall Transplant alone
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03310905
The ClinicalTrials.gov registry entry for NCT03310905 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 5 other Transplant;Failure,Kidney trials with a reported enrollment target (94% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Transplant;Failure,Kidney appearing as the primary indexed condition, and to 2 interventions - of which Abdominal Wall Transplant with another solid organ transplant is the first listed.
NCT03310905 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03310905 about?
NCT03310905 is a clinical study titled "Abdominal Wall Transplant". The purpose of this protocol is to determine the safety and efficacy of abdominal wall transplantation as a treatment for the reconstruction of abdominal wall defects. Abdominal wall transplantation may be performed alone or in combination with another transplant.
What is the current status of trial NCT03310905?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2018-05-01. Estimated completion is 2028-06-01.
What conditions does trial NCT03310905 study?
This clinical trial studies the following conditions: Transplant;Failure,Kidney, Transplant; Failure, Liver, Abdominal Wall Hernia, Transplant; Failure, Bowel, Abdominal Wall Defect.
What interventions are being tested in trial NCT03310905?
The interventions under investigation include: Abdominal Wall Transplant with another solid organ transplant (PROCEDURE), Abdominal Wall Transplant alone (PROCEDURE).
Who is sponsoring clinical trial NCT03310905?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03310905 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transplant;Failure,Kidney
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
-
Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
RECRUITING · NA
-
TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
RECRUITING · Phase 4
-
Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
ACTIVE NOT RECRUITING · Phase 1
-
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
COMPLETED · Phase 4
Explore more on PlainTrial
Transplant;Failure,Kidney
All registered trials for this condition
Transplant; Failure, Liver
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.